- Home
- BCAB vs MODD Comparison
BCAB vs MODD Comparison
Compare BCAB & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- MODD
- Stock Information
- Founded
- BCAB 2007
- MODD 1998
- Country
- BCAB United States
- MODD United States
- Employees
- BCAB N/A
- MODD N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- MODD Industrial Specialties
- Sector
- BCAB Health Care
- MODD Health Care
- Exchange
- BCAB Nasdaq
- MODD Nasdaq
- Market Cap
- BCAB 40.5M
- MODD 33.0M
- IPO Year
- BCAB 2020
- MODD N/A
- Fundamental
- Price
- BCAB $0.78
- MODD $0.54
- Analyst Decision
- BCAB Hold
- MODD
- Analyst Count
- BCAB 3
- MODD 0
- Target Price
- BCAB $1.00
- MODD N/A
- AVG Volume (30 Days)
- BCAB 1.2M
- MODD 1.6M
- Earning Date
- BCAB 11-13-2025
- MODD 11-14-2025
- Dividend Yield
- BCAB N/A
- MODD N/A
- EPS Growth
- BCAB N/A
- MODD N/A
- EPS
- BCAB N/A
- MODD N/A
- Revenue
- BCAB N/A
- MODD N/A
- Revenue This Year
- BCAB N/A
- MODD N/A
- Revenue Next Year
- BCAB N/A
- MODD N/A
- P/E Ratio
- BCAB N/A
- MODD N/A
- Revenue Growth
- BCAB N/A
- MODD N/A
- 52 Week Low
- BCAB $0.24
- MODD $0.46
- 52 Week High
- BCAB $2.05
- MODD $2.25
- Technical
- Relative Strength Index (RSI)
- BCAB 55.58
- MODD 47.20
- Support Level
- BCAB $0.62
- MODD $0.46
- Resistance Level
- BCAB $0.73
- MODD $0.60
- Average True Range (ATR)
- BCAB 0.09
- MODD 0.06
- MACD
- BCAB 0.00
- MODD 0.00
- Stochastic Oscillator
- BCAB 47.44
- MODD 49.45
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.